No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ABBV240719P152500
- 0.03
- -0.06-66.67%
15min DelayClose Jul 12 15:59 ET
0.11High0.03Low
0.11Open0.09Pre Close3 Volume133 Open Interest152.50Strike Price18.00Turnover42.06%IV10.46%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.0105Delta0.0034Gamma5676.00Leverage Ratio-0.0184Theta-0.0002Rho-59.43Eff Leverage0.0055Vega
Intraday
- 5D
- Daily
News
Morgan Stanley Sees $180B Patent Cliff, $380B Deal Capacity Fueling Biopharma M&A
These Are the Weight Loss Drug Stocks With the Most Upside - SA Sentiment Survey
AbbVie Earnings Preview: What to Expect
Express News | AbbVie Submits Applications To FDA And EMA For New Indication Of Upadacitinib (RINVOQ) For Treatment Of Giant Cell Arteritis; Supported By Phase 3 SELECT-GCA Study Showing Sustained Remission And Consistent Safety Profile
Express News | Abbvie Submits Regulatory Applications to FDA and EMA for Upadacitinib (Rinvoq®) in Giant Cell Arteritis
Dividend Roundup: Procter & Gamble, Costco, CVS Health, Colgate-Palmolive, and More
Comments
$Genmab(GMAB.US$ $AbbVie(ABBV.US$
EPKINLY (Epcoritamab) Now Approved for Patients w/ Follicular Lymphoma (FL)
» Positive results in Ph1/2 EPCORE® NHL-1 study for R/R FL
» Offers off-the-shelf T-cell therapy
» First-of-its-kind antibody for both R/R FL & DLBCL after prior treatments (2+ lines)
EPKINLY (Epcoritamab) Now Approved for Patients w/ Follicular Lymphoma (FL)
» Positive results in Ph1/2 EPCORE® NHL-1 study for R/R FL
» Offers off-the-shelf T-cell therapy
» First-of-its-kind antibody for both R/R FL & DLBCL after prior treatments (2+ lines)
3
$Chevron(CVX.US$
One of the U.S.’s largest energy corporations, Chevron Corporation (NYSE:CVX) specializes in oil, gas and renewable fuels. The company has upstream and downstream operations focused on the oil and gas industry. Oil companies are an interesting pick since the best ones are known for paying dividends, even in bad times.
Chevron has a 37-year history of increasing dividends and has consistently paid them since ...
One of the U.S.’s largest energy corporations, Chevron Corporation (NYSE:CVX) specializes in oil, gas and renewable fuels. The company has upstream and downstream operations focused on the oil and gas industry. Oil companies are an interesting pick since the best ones are known for paying dividends, even in bad times.
Chevron has a 37-year history of increasing dividends and has consistently paid them since ...
33
3
From YouTube
6
Interesting both for the (1) shift in the macro-trend to M&A (vs. Licensing) and (2) change in top spenders
$Merck & Co(MRK.US$ $Bristol-Myers Squibb(BMY.US$ $Johnson & Johnson(JNJ.US$ $Pfizer(PFE.US$ $Novo-Nordisk A/S(NVO.US$ $AbbVie(ABBV.US$
$Merck & Co(MRK.US$ $Bristol-Myers Squibb(BMY.US$ $Johnson & Johnson(JNJ.US$ $Pfizer(PFE.US$ $Novo-Nordisk A/S(NVO.US$ $AbbVie(ABBV.US$
10
1
Read more